IN2014MN02392A - - Google Patents

Info

Publication number
IN2014MN02392A
IN2014MN02392A IN2392MUN2014A IN2014MN02392A IN 2014MN02392 A IN2014MN02392 A IN 2014MN02392A IN 2392MUN2014 A IN2392MUN2014 A IN 2392MUN2014A IN 2014MN02392 A IN2014MN02392 A IN 2014MN02392A
Authority
IN
India
Prior art keywords
tomato extracts
exclusively
preparing
blood pressure
technology relating
Prior art date
Application number
Inventor
Asim K Duttaroy
Original Assignee
Univ Oslo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Oslo filed Critical Univ Oslo
Publication of IN2014MN02392A publication Critical patent/IN2014MN02392A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/31—Extraction of the material involving untreated material, e.g. fruit juice or sap obtained from fresh plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/55—Liquid-liquid separation; Phase separation

Abstract

Provided herein is technology relating to tomato extracts and particularly but not exclusively to preparing and using tomato extracts as an anti hypertensive agent to modulate blood pressure.
IN2392MUN2014 2012-04-23 2013-04-22 IN2014MN02392A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261636813P 2012-04-23 2012-04-23
PCT/US2013/037524 WO2013163057A1 (en) 2012-04-23 2013-04-22 Use of tomato extract as antihypertensive agent and process for making water soluble sugar free tomato extract

Publications (1)

Publication Number Publication Date
IN2014MN02392A true IN2014MN02392A (en) 2015-08-21

Family

ID=48225147

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2392MUN2014 IN2014MN02392A (en) 2012-04-23 2013-04-22

Country Status (15)

Country Link
US (3) US20150132371A1 (en)
EP (1) EP2844083B1 (en)
JP (4) JP2015515493A (en)
CN (2) CN104363774A (en)
AU (1) AU2013252637B2 (en)
CA (1) CA2881555C (en)
DK (1) DK2844083T3 (en)
ES (1) ES2692158T3 (en)
HK (1) HK1205880A1 (en)
IN (1) IN2014MN02392A (en)
NZ (1) NZ630482A (en)
PL (1) PL2844083T3 (en)
PT (1) PT2844083T (en)
TR (1) TR201815457T4 (en)
WO (1) WO2013163057A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015515493A (en) 2012-04-23 2015-05-28 ユニバーシティ オブ オスロＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｏｓｌｏ Use of tomato extract as an antihypertensive agent and method for producing tomato extract without water-soluble sugar
GB201223365D0 (en) 2012-12-24 2013-02-06 Provexis Natural Products Ltd Compositions
BR112019008687B1 (en) 2016-11-02 2023-02-07 Provexis Natural Products Limited COMPOSITION COMPRISING A WATER SOLUBLE TOMATO EXTRACT (WSTE)
CN109380728B (en) * 2018-10-17 2022-03-22 汤臣倍健股份有限公司 Composition and health food with auxiliary blood pressure lowering effect
WO2020166494A1 (en) * 2019-02-15 2020-08-20 国立大学法人信州大学 Eggplant-derived composition having blood pressure-lowering action
CN110638902A (en) * 2019-09-30 2020-01-03 白冬平 Application of tomato extract in preparation of antihypertensive drug and antihypertensive composition thereof
DE102020001722A1 (en) 2020-03-14 2021-09-16 DÖHLER GmbH A method for producing an aroma-laden gas, aroma-laden gas and using the aroma-laden gas
WO2022238727A1 (en) * 2021-05-08 2022-11-17 Momand Hossay Methods for preparing white heirloom tomato-based compositions for skin lightening via enhanced glutathione, and associated compositions thereof
CN114617920B (en) * 2022-04-11 2023-10-13 汤臣倍健股份有限公司 Water-soluble tomato extract with memory improving function and application thereof
GB202208323D0 (en) * 2022-06-07 2022-07-20 Provexis Natural Products Ltd Compostions

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6467173A (en) 1987-09-04 1989-03-13 Sanei Kagaku Kogyo Kk Preparation of vegetable or fruit juices
JP2722670B2 (en) * 1989-05-30 1998-03-04 ライオン株式会社 Food and drink for preventing hypertension and method for producing the same
JP2997358B2 (en) 1992-01-30 2000-01-11 ポーラ化成工業株式会社 External preparation for skin
WO1994003421A2 (en) 1992-07-30 1994-02-17 Cal International Limited Esters and combinations of an organic nitrate and a salicylate
US5502038A (en) 1993-06-21 1996-03-26 Medical Research Foundation Of Oregon Cholesterol sequestrant glycosides that inhibit intestinal cholesterol absorption
JP2905725B2 (en) * 1995-07-01 1999-06-14 カゴメ株式会社 Food composition derived from tomato
FR2759904B1 (en) 1997-02-25 2000-01-28 Alma Heny Reza COMPOSITIONS FOR COSMETIC AND / OR PHARMACEUTICAL AND / OR DERMATOLOGICAL USE AND METHODS OF MAKING SAME
DE19720767A1 (en) 1997-05-07 1998-11-12 Protekum Umweltinstitut Gmbh O Use of e.g. p-hydroxybenzoic acid, gallic acid, vanillic acid, syringic acid, myricetin, quercetin and camphor oil
GB9808796D0 (en) * 1998-04-24 1998-06-24 Rowett Research Services Limit Antithrombotic agents
ES2197573T3 (en) 1998-09-02 2004-01-01 Unilever N.V. TOMATO PRODUCTS ENRIQUECIDOS IN BETA-CICLOCITRAL.
AU5965399A (en) 1998-10-12 2000-05-01 Andreas Bockelmann Pharmaceutically active composition
CN1352941A (en) 2000-11-11 2002-06-12 吉建军 Linoleic acid capsule
CA2446274A1 (en) 2001-05-04 2002-11-14 Ato B.V. Novel regulatory protein
DE10300049A1 (en) 2003-01-03 2004-07-15 Morphochem AG Aktiengesellschaft für kombinatorische Chemie New compounds that inhibit factor VIIa
ITMI20020632A1 (en) 2002-03-27 2003-09-29 Indena Spa PROCESS FOR THE PREPARATION OF HIGH-LYCOPENE TOMATO EXTRACTS
AU2003261903A1 (en) 2002-11-06 2004-06-07 Kao Corporation Blood fluidity improving agent
AU2004235702B2 (en) 2003-03-27 2008-07-31 Unigen Inc. Composition comprising bamboo extract and the compounds isolated therefrom showing treating and preventing activity for inflammatory and blood circulation disease
JP4571783B2 (en) 2003-04-14 2010-10-27 林原 健 Antimicrobial agent
US20040223962A1 (en) 2003-05-07 2004-11-11 Riordan Neil H. Method and composition for preventing or reducing edema, deep vein thrombosis and/or pulmonary embolism
EP1481669A1 (en) 2003-05-30 2004-12-01 Yamanouchi Pharmaceutical Co. Ltd. Use of polyhydroxy phenols and polyphenols for modulating p-selectin activity
ATE424898T1 (en) 2003-08-21 2009-03-15 Nestec Sa NATURAL LYCOPEN CONCENTRATES AND PROCESS FOR PRODUCTION
JP2004137287A (en) * 2003-12-08 2004-05-13 Kao Corp Prophylactic/therapeutic agent for hypertension
FR2871378B1 (en) 2004-06-15 2007-03-30 Seppic Sa NOVEL MEDICINAL PRODUCT BASED ON FLAVANOIS AND THEIR DERIVATIVES AND USE THEREOF FOR OBTAINING A MEDICAMENT FOR THE PREVENTION OF RESTENOSIS AND ATHEROMATOUS DISEASE IN CORONARY PATIENTS
EP1640001A1 (en) 2004-09-24 2006-03-29 New Pharma Investments Holding Composition against cardiovascular diseases
CN100488535C (en) 2004-12-09 2009-05-20 郭富凤 Lycopin mixture
US7419960B2 (en) 2005-01-07 2008-09-02 Hong Kong Baptist University Hemiterpene glycosides with anti-platelet aggregation activities from Ilex pubescens
JP2006193435A (en) 2005-01-11 2006-07-27 Kagome Co Ltd Fatigue-improving agent
GB0502985D0 (en) 2005-02-14 2005-03-16 Provexis Ltd Therapeutic uses of tomato extracts
WO2006094120A2 (en) 2005-03-02 2006-09-08 The Regents Of The University Of California Treatment for embolic stroke
JP4260158B2 (en) 2005-07-07 2009-04-30 長谷川香料株式会社 Method for producing tomato juice concentrate and tomato flavor composition
US20070082071A1 (en) 2005-10-07 2007-04-12 Willimann John A Composition for controlling the respiratory effects of inhaled pollutants & allergens
AT503521A1 (en) 2006-05-05 2007-11-15 Omnica Gmbh USE OF AN EXTRACT OF KIWI FRUIT
GB0610790D0 (en) 2006-06-02 2006-07-12 Provexis Natural Products Ltd Therapeutic uses of tomato extracts
US20080009449A1 (en) 2006-07-07 2008-01-10 Kailash Prasad Lignan complex derived from flax seed used for treatment of hypercholesterolemic atherosclerosis
SG191445A1 (en) 2006-12-22 2013-07-31 Univ Johns Hopkins Anti-cholesterolemic compounds and methods of use
WO2008131047A2 (en) 2007-04-16 2008-10-30 The Regents Of The University Of Michigan Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism
EP2036568A1 (en) 2007-09-12 2009-03-18 Nestec S.A. Wolfberries and inflammation
JP2009240191A (en) 2008-03-31 2009-10-22 Shimizu Shoko Kaigisho Enhancement of expression of synthetic gene of lignans/lignins by light irradiation
GB0819958D0 (en) 2008-10-31 2008-12-10 Provexis Natural Products Ltd Therapeutic compositions
GB0819959D0 (en) * 2008-10-31 2008-12-10 Provexis Natural Products Ltd Fruit extracts
CA2785581A1 (en) 2009-12-24 2011-06-30 Stanley Kubow Compositions and methods for preventing and treating diseases and environmentally induced health disorders
JP6058872B2 (en) * 2010-01-18 2017-01-11 キッコーマン株式会社 GABA-rich tomato-derived composition having anti-stress action
JP2015515493A (en) 2012-04-23 2015-05-28 ユニバーシティ オブ オスロＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｏｓｌｏ Use of tomato extract as an antihypertensive agent and method for producing tomato extract without water-soluble sugar
GB201223365D0 (en) 2012-12-24 2013-02-06 Provexis Natural Products Ltd Compositions
BR112019008687B1 (en) 2016-11-02 2023-02-07 Provexis Natural Products Limited COMPOSITION COMPRISING A WATER SOLUBLE TOMATO EXTRACT (WSTE)

Also Published As

Publication number Publication date
JP2021008474A (en) 2021-01-28
PT2844083T (en) 2018-11-12
JP2019038844A (en) 2019-03-14
CN104363774A (en) 2015-02-18
US20180271926A1 (en) 2018-09-27
DK2844083T3 (en) 2018-11-12
JP2015515493A (en) 2015-05-28
HK1205880A1 (en) 2015-12-31
CN107397830A (en) 2017-11-28
TR201815457T4 (en) 2018-11-21
AU2013252637B2 (en) 2016-12-22
US10864241B2 (en) 2020-12-15
CA2881555A1 (en) 2013-10-31
NZ630482A (en) 2016-11-25
AU2013252637A1 (en) 2014-12-04
ES2692158T3 (en) 2018-11-30
EP2844083B1 (en) 2018-07-25
WO2013163057A1 (en) 2013-10-31
PL2844083T3 (en) 2018-12-31
CA2881555C (en) 2021-10-19
US20150132371A1 (en) 2015-05-14
JP2023009053A (en) 2023-01-19
EP2844083A1 (en) 2015-03-11
US20210236578A1 (en) 2021-08-05

Similar Documents

Publication Publication Date Title
IN2014MN02392A (en)
PH12015501720B1 (en) Modulators of methyl modifying enzymes, compositions and uses thereof
MY167585A (en) Disposable diaper
JO3773B1 (en) P2x7 modulators
MX2013008390A (en) Preparation of metal-triazolate frameworks.
MY170302A (en) Process for the preparation of an aqueous solution comprising at least one earth alkali hydrogen carbonate and its use
JO3241B1 (en) Process for the preparation of an aqueous solution comprising at least one earth alkali hydrogen carbonate and its use
HK1208702A1 (en) Compositions and methods for modulation of fgfr3 expression fgfr3
EP3075817A4 (en) Process and system for coupling pressurized pyrolysis of biomasses
MY168166A (en) Polymer and Composition Including Same, and Adhesive Composition
EP3068357A4 (en) Pressure enhanced incontinence pad and methods
CA2905610C (en) Hyaluronic acid derivatives
EP3052620A4 (en) Processes for increasing enzymatic hydrolysis of cellulosic material
GB2519697A (en) Golf fitting systems and related methods
GB201016832D0 (en) Garment technology for application of therapeutic pressure
DK2564338T3 (en) SYSTEMS FOR MODULATION OF PRESSURE WAVE THERAPY
EP2909374A4 (en) Novel creping adhesives and methods to monitor and control their application
WO2013163297A8 (en) Modified glycoproteins
WO2014124307A3 (en) Targeted theranostics
EP3030142A4 (en) Intra-abdominal pressure to promote hemostasis and survival
EP2934474A4 (en) Modulation of melanogenesis by modification of tyrosinase by palmitoylation
EP2948143A4 (en) Use of phenoxypropylamine compounds to treat depression
SG11201500032SA (en) High pressure seal back-up
PL2877699T3 (en) Low pressure turbine
IS8889A (en) Hydrogenated glycerine treatment at low pressure to produce mixed products